DLH Holdings (DLHC)
NASDAQ:DLHC
Want to see DLHC full AI Analyst Report?
DLHC Stock Chart & Stats
$6.36
$0.05(0.65%)
At close: 4:00 PM EST
$6.36
$0.05(0.65%)
Day’s Range― - ―
52-Week Range$4.95 - $8.10
Previous CloseN/A
Volume6.05K
Average Volume (3M)27.65K
Market Cap
$80.44M
Enterprise Value$225.88M
Total Cash (Recent Filing)$131.00K
Total Debt (Recent Filing)$145.58M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Aug 05, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding14,493,035
10 Day Avg. Volume37,306
30 Day Avg. Volume27,646
Financial Highlights & Ratios
PEG Ratio-0.73
Price to Book (P/B)0.72
Price to Sales (P/S)0.24
P/FCF Ratio3.54
Enterprise Value/Market Cap2.81
Enterprise Value/Revenue0.77
Enterprise Value/Gross Profit4.54
Enterprise Value/Ebitda9.66
Forecast
1Y Price Target
$10.00Price Target Upside57.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.46
Revenue Forecast (FY)$234.89M
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationSustained positive operating and free cash flow (~$19M TTM) gives DLH durable internal liquidity to fund operations, service debt, and invest selectively. Even with net losses, consistent cash conversion supports deleveraging and cushions timing mismatches in federal procurement cycles.
Deleveraging And Covenant ComplianceManagement’s active debt reduction (debt down QoQ and plan to convert 50–55% of EBITDA to debt paydown) demonstrates discipline that strengthens long-term financial flexibility, reduces covenant risk, and improves capacity to absorb contract lulls inherent in government services businesses.
Sole‑source NIH Extension And Pipeline VisibilityA two‑year sole‑source NIH extension provides multi-year revenue visibility in DLH’s core federal health niche, reinforcing customer relationships and recurring revenue potential. Coupled with management’s cited improving pipeline, this helps offset concentration shocks from other contract transitions.
Bears Say
Steep Revenue DeclineA roughly one‑third YoY revenue drop reflects material loss of program volume and reduces operating leverage. Persistently lower revenue would pressure margins, cash flow trajectory, and the company's ability to rebuild scale in federal health services amid competitive recompetes and set‑aside dynamics.
Elevated LeverageDespite recent paydowns, materially elevated debt-to-equity (~1.3x TTM) and negative ROE limit strategic flexibility. If revenue and net income remain pressured, servicing and reducing leverage could crowd out investments or force sharper cost cutting, constraining long‑term growth execution.
Contract Concentration & Set‑aside TransitionsConversion of legacy work (e.g., VA CMOP) to small business set‑asides is a structural revenue loss that reduces the company’s addressable workload and predictability. Combined with procurement timing and protest risks, this raises the odds of prolonged revenue volatility during recompetes.
DLH Holdings News
DLHC FAQ
What was DLH Holdings’s price range in the past 12 months?
DLH Holdings lowest stock price was $4.95 and its highest was $8.10 in the past 12 months.
What is DLH Holdings’s market cap?
DLH Holdings’s market cap is $80.44M.
When is DLH Holdings’s upcoming earnings report date?
DLH Holdings’s upcoming earnings report date is Aug 05, 2026 which is in 75 days.
How were DLH Holdings’s earnings last quarter?
DLH Holdings released its earnings results on May 06, 2026. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.01.
Is DLH Holdings overvalued?
According to Wall Street analysts DLH Holdings’s price is currently Undervalued.
Does DLH Holdings pay dividends?
DLH Holdings does not currently pay dividends.
What is DLH Holdings’s EPS estimate?
DLH Holdings’s EPS estimate is -0.17.
How many shares outstanding does DLH Holdings have?
DLH Holdings has 14,493,035 shares outstanding.
What happened to DLH Holdings’s price movement after its last earnings report?
DLH Holdings reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went up 2.321%.
Which hedge fund is a major shareholder of DLH Holdings?
Currently, no hedge funds are holding shares in DLHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DLH Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (57.23% Upside)
$10.00 (57.23% Upside)
Insider Transactions
Bought Shares
Worth $432.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-26.72%
12-Months-Change
Fundamentals
Return on Equity
-4.00%
Trailing 12-Months
Asset Growth
-9.75%
Trailing 12-Months
Company Description
DLH Holdings
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range of human services and solutions, which consists of monitoring and evaluation, electronic medical records migration, data collection and management, and nutritional and social health assessments; and IT system architecture design, migration plan, and ongoing maintenance services. In addition, the company offers public health and life sciences services, such as clinical trials, epidemiology studies, and disease prevention; and health promotion to underserved and at-risk communities through development of strategic communication campaigns, research on emerging trends, health informatics analyses, and application of best practices. It primarily serves the federal health services market. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.
DLHC Company Deck
DLHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call communicated a mixed picture: material near-term financial headwinds with a steep year-over-year revenue decline (~33.5%) and a sharp drop in adjusted EBITDA (~43.6%), largely driven by program transitions to small business set-asides and contract completions. Offsetting these negatives, management reported margin resilience (9% adjusted EBITDA margin), positive free cash flow (~$3.8M), resumed deleveraging (debt reduced to $132.7M), a two-year NIH contract extension adding revenue visibility, recognition for technology capabilities, and an improving pipeline as delayed procurements return to market. Risks remain around federal health reprioritization and typical government procurement timing uncertainty, but the company appears to be stabilizing its cost structure and positioning for upcoming opportunities.View all DLHC earnings summariesDLHC Stock 12 Month Forecast
Average Price Target
$10.00
▲(57.23% Upside)
Technical Analysis
Ownership Overview
35.51% Insiders
7.37% Mutual Funds
26.87% Other Institutional Investors
26.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---